Since IGFBPs can bind to IGFs to inhibit or potentiate their bioactivity, it is conceivable that IGFBP2 dysregulation could affect IGFs signaling in the development and maintenance of skeletal and dental tissues, contributing to tooth/bone disorders. This evidence concerns the gene IGFBP2 and bone disorder.